Zobrazeno 1 - 10
of 36
pro vyhledávání: '"L. Barkoff"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S506
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S507
Autor:
K.R. Sweat, B. Kaufman, L. Barkoff, C. Chen, E. Profita, E. Lee, M. Rosenberg, S. Chen, S. Hollander, C. Almond
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S509
Autor:
Jerrid Brabender, L. Barkoff, Angela C. Chen, Katie Jo Stauffer, Faustine D. Ramirez, Jeffrey Kazmucha, S. Stillman Berry, David N. Rosenthal, Donna C. Lee, C. Jason Wang, Susan E. Nourse, Inger Olson, Nancy McDonald, Elif Seda Selamet Tierney, Sarah C. Couch
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Pediatric heart transplant recipients have high‐risk cardiovascular profiles that can affect their long‐term outcomes; however, promoting exercise and healthy diet has not been a major focus in the field. The objective of this study wa
Autor:
J. Lee, David N. Rosenthal, L. Barkoff, Kenneth I. Weinberg, Shuping Chen, Seth A. Hollander, Daniel Bernstein, H. Ahmed, Donna C. Lee
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S120
Purpose To understand whether patients who have undergone Fontan palliation may have a higher susceptibility to post-HT infections given thymectomy in infancy and known depletions of T-cell subsets. Methods This was a single-center, retrospective coh
Autor:
John C. Dykes, L. Barkoff, Daniel Bernstein, Seth A. Hollander, Beth D. Kaufman, Harvey J. Cohen, Sharon Chen, Barbara Sourkes, David N. Rosenthal
Publikováno v:
Journal of Pain and Symptom Management. 53:927-931
Context Despite advances in therapies, many pediatric heart transplant (Htx) recipients will die prematurely. We characterized the circumstances surrounding death in this cohort, including location of death and interventions performed in the final 24
Autor:
Seth A. Hollander, Kevin P. Daly, Joseph W. Rossano, Matthew Fenton, J. Lee, Ashwin K. Lal, M.J. Bock, Christopher S. Almond, Gloria L. Klein, Elfriede Pahl, L. Barkoff, Lynn A. Sleeper, Chesney Castleberry
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S207-S208
Purpose Currently there are no-FDA approved immunosuppressants specific to pediatric heart transplantation (HT). In recent years, everolimus (EVL) has emerged as an alternative to tacrolimus (TAC) as a primary immunosuppressant to prevent rejection t
Autor:
Seth A. Hollander, John C. Dykes, Beth D. Kaufman, E. Profita, Donna C. Lee, L. Barkoff, J. Lee, Shuping Chen, Daniel Bernstein, H. Ahmed, David N. Rosenthal
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S452-S453
Purpose Infectious complications are a major cause of morbidity & mortality after heart transplantation (HT). Patients who have undergone Fontan palliation may have a higher susceptibility to post HT infections given thymectomy in infancy and known d
Autor:
David N. Rosenthal, Seth A. Hollander, L. Barkoff, Sarah J. Wilkens, Beth D. Kaufman, James R. Priest
Publikováno v:
Pediatric transplantationREFERENCES. 24(1)
Purpose We sought to determine whether the presence of a systemic SA with potential complicating factors affects waitlist and post-HT outcomes in pediatric patients. Methods This is a single-center retrospective review of pediatric patients listed fo